Nest building performance following MPTP toxicity in mice

Behavioural Brain Research

Volumn 208, Issue 2, 2010, Pages 444-449

  Sager, Thomas Nikolaj ^a   Kirchhoff, Jeppe ^a   Mørk, Arne ^a   Van Beek, Johan ^a   Thirstrup, Kenneth ^a   Didriksen, Michael ^a   Lauridsen, Jes Brix ^a,b  

^a H LUNDBECK A S   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Dopamine; Mice; Motor behavior; MPTP; Nest building; Parkinson's disease; Striatum; Tyrosine hydroxylase

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DYSFUNCTION; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; IMMUNOHISTOCHEMISTRY; LIMB MOVEMENT; MALE; MENTAL PERFORMANCE; MOUSE; NEST BUILDING PERFORMANCE; NEUROPROTECTION; NON INVASIVE PROCEDURE; NONHUMAN; OUTCOME ASSESSMENT; PLASTICITY; PRIORITY JOURNAL; TRAINING;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; BEHAVIOR, ANIMAL; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MICE, INBRED C57BL; MPTP POISONING; NESTING BEHAVIOR; NEUROTOXINS; RECOVERY OF FUNCTION; TIME FACTORS; TYROSINE 3-MONOOXYGENASE;

EID: 77249106427     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2009.12.014     Document Type: Article

References (24)

1. Balcombe J.P., Barnard N.D., and Sandusky C. Laboratory routines cause animal stress. Contemp Top Lab Anim Sci 43 6 (2004) 42-51
2. Feng W., Wei H., and Liu G.T. Pharmacological study of the novel compound FLZ against experimental Parkinson's models and its active mechanism. Mol Neurobiol 31 1-3 (2005) 295-300
3. Fernagut P.O., Diguet E., Labattu B., and Tison F. A simple method to measure stride length as an index of nigrostriatal dysfunction in mice. J Neurosci Methods 113 2 (2002) 123-130
4. Fleming S.M., Salcedo J., Fernagut P.O., Rockenstein E., Masliah E., Levine M.S., et al. Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein. J Neurosci 24 42 (2004) 9434-9440
5. Heikkila R.E., Cabbat F.S., Manzino L., and Duvoisin R.C. Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine on neostriatal dopamine in mice. Neuropharmacology 23 6 (1984) 711-713
6. Hofele K., Sedelis M., Auburger G.W., Morgan S., Huston J.P., and Schwarting R.K. Evidence for a dissociation between MPTP toxicity and tyrosinase activity based on congenic mouse strain susceptibility. Exp Neurol 168 1 (2001) 116-122
7. Huston J.P., Nef B., Papadopoulos G., and Welzl H. Activation and lateralization of sensorimotor field for perioral biting reflex by intranigral GABA agonist and by systemic apomorphine in the rat. Brain Res Bull 5 6 (1980) 745-749
8. Kirchhoff J., Mork A., Brennum L.T., and Sager T.N. Striatal extracellular dopamine levels and behavioural reversal in MPTP-lesioned mice. Neuroreport 20 5 (2009) 482-486
9. Kolb B., and Whishaw I.Q. Neonatal frontal lesions in hamsters impair species-typical behaviors and reduce brain weight and neocortical thickness. Behav Neurosci 99 4 (1985) 691-706
10. Langston J.W. MPTP neurotoxicity: an overview and characterization of phases of toxicity. Life Sci 36 3 (1985) 201-206
11. Luchtman D.W., Shao D., and Song C. Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson's disease. Physiol Behav 98 1-2 (2009) 130-138
12. Lynch C.B. Response to divergent selection for nesting behavior in Mus musculus. Genetics 96 3 (1980) 757-765
13. Morissette M., Al Sweidi S., Callier S., and Di Paolo T. Estrogen and SERM neuroprotection in animal models of Parkinson's disease. Mol Cell Endocrinol 290 1-2 (2008) 60-69
14. Nishi K., Kondo T., and Narabayashi H. Difference in recovery patterns of striatal dopamine content, tyrosine hydroxylase activity and total biopterin content after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration: a comparison of young and older mice. Brain Res 489 1 (1989) 157-162
15. Ogawa N., Hirose Y., Ohara S., Ono T., and Watanabe Y. A simple quantitative bradykinesia test in MPTP-treated mice. Res Commun Chem Pathol Pharmacol 50 3 (1985) 435-441
16. Rozas G., Lopez-Martin E., Guerra M.J., and Labandeira-Garcia J.L. The overall rod performance test in the MPTP-treated-mouse model of Parkinsonism. J Neurosci Methods 83 2 (1998) 165-175
17. Schmidt N., and Ferger B. Neurochemical findings in the MPTP model of Parkinson's disease. J Neural Transm 108 11 (2001) 1263-1282
18. Sedelis M., Hofele K., Auburger G.W., Morgan S., Huston J.P., and Schwarting R.K. MPTP susceptibility in the mouse: behavioral, neurochemical, and histological analysis of gender and strain differences. Behav Genet 30 3 (2000) 171-182
19. Sedelis M., Schwarting R.K., and Huston J.P. Behavioral phenotyping of the MPTP mouse model of Parkinson's disease. Behav Brain Res 125 1-2 (2001) 109-125
20. Sluyter F., Bult A., Lynch C.B., van Oortmerssen G.A., and Koolhaas J.M. A comparison between house mouse lines selected for attack latency or nest-building: evidence for a genetic basis of alternative behavioral strategies. Behav Genet 25 3 (1995) 247-252
21. Tillerson J.L., Caudle W.M., Parent J.M., Gong C., Schallert T., and Miller G.W. Olfactory discrimination deficits in mice lacking the dopamine transporter or the D2 dopamine receptor. Behav Brain Res 172 1 (2006) 97-105
22. Tillerson J.L., and Miller G.W. Grid performance test to measure behavioral impairment in the MPTP-treated-mouse model of parkinsonism. J Neurosci Methods 123 2 (2003) 189-200
23. Upchurch M., and Schallert T. A behavior analysis of the offspring of "haloperidol-sensitive" and "haloperidol-resistant" gerbils. Behav Neural Biol 39 2 (1983) 221-228
24. Weidong L., Shen C., and Jankovic J. Etiopathogenesis of Parkinson disease: a new beginning?. Neuroscientist 15 1 (2009) 28-35